16 Jan

CROWN BAUS CAPITAL (OTC: CBCA) ACQUIRES MILITARY GRADE CRYPTOGRAPHIC SECURE ONLINE COMMUNICATIONS SYSTEM; CANNABIS SCIENCE (OTC: CBIS) MEASURES ASSET BACKED BLOCKCHAIN CRYPTOCURRENCY USAGE WITH CRYPTOGRAPHIC SYSTEMS INTEGRATION

BEVERLY HILLS, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) — Crown Baus Capital, Inc., (CBCA) a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment & Media, Education, and Financial Services is pleased to announce it has acquired a military grade CryptoGraphic secure Online Communications System, Cannabis Science (CBIS) measures blockchain CryptoCurrency usage with asset backed, CryptoGraphic systems and general public multiple application usage. The CBIS Security Team (CBISST) will be integrating the CBCA CrytopGraphics system between the two companies adding a unique concept for security and privacy issues to the new and burgeoning blockchain CryptoCurrency industry.

This marks the release of the first CryptoGraphic messenger mobile application of its kind. The secure message system introduces “Ghost Chat,” which is a new way to privately communicate with friends, family, and business associates. When you walk into the grocery store and buy some groceries, you don’t need to fill out an application form and submit your ID to pay with cash: you just pay and go. This type of CryptoGraphic interface allows the same type of transaction, only difference is; it’s all done online.

The Crown Baus CryptoGraphics systems offers many special and unique features to protect a user’s identity while communicating designed for sending data back and forth over the internet and other “secure” communications ports. For example, with the selection of a built-in countermeasures such as “Self-Destruct” which automatically destroys a message once it’s opened, is a simple example of government or military levels of classified communication protection.

This type of CryptoGraphic transaction with connected integration will set a new standard for security and privacy. In today’s world privacy and security are hard to come by; this will ease the fears of people tapping in confidential information for all.

The CryptoGraphic secure message system takes a different approach. It starts off by eliminating the registration process altogether and assigns every user a unique four-digit ID. This feature, entitled “Ghost Chat,” allows users to chat with one another without sharing their private mobile phone number or personal data. Completely anonymous chats can begin in two clicks, simply by adding the user ID. Once a user logs out the ID is wiped clean and a new ID is assigned on the next use. This secure communication is Ideal for Government and Military usage: Cryptographic Security includes designing and using technically sound cryptosystems. Cryptographic systems are used to protect classified and sensitive data transfers between all Government and Military Agencies.

These systems range from highly classified Type 1 Military rated systems to sensitive but unclassified (SBU) commercial off the shelf (COTS) systems. The app’s Self-Destruct: A government or military grade level of communication protection because of the wide-ranging nature of the threats to communication systems. No matter the classification the basic measures for protecting communication from comprise is specifically designed into the app, even to protect communication threats to national security. The secure message system also protects the user’s data by converting text data into binary jpeg files, which adds an additional layer of security to chat stream.

Chat apps have become extremely popular as users use them daily with friends and family from all over the world. While many are using giant text-messaging apps such as WhatsApp, WeChat, Facebook Messenger, and Line, there are growing concerns over the current trending privacy matters worldwide. This sparked several new privacy text-message apps like Wickr, Signal and Telegram to hit the market.

About Crown Baus Capital Corp.

Crown Baus Capital Corp. is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment & Media, Education, and Financial Services. The Company specializes in the vertical integration of industrial, commercial, and retail profit centers, along with partnerships and start-ups, to create synergistic savings and increased value to our shareholders.

Forward-Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition. Crown Baus Capital Corporation does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a ‘safe harbor’ for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties.
These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.

Contact:

Crown Baus Capital Corp.
Raymond C. Dabney
President & CEO, Co-Founder
T: +1 (888) 263-0948
info@crownbaus.com

03 Jan

Cannabis Science Negotiates With Crown Baus Capital Corp CBCA for Future Blockchain Cryptocurrency ICO Growth While Adding Strength to its Pharmacy Openings and Pharmaceutical Drug Development Programs

IRVINE, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (OTC Pink: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce its intent to partner with its sister company, Crown Baus Capital Corporation (OTC Pink: CBCA), to strengthen CBIS’ planned blockchain crypto-currency ICO offering.

Details of the CBIS and CBCA cryptocurrency blockchain arrangement are expected to be finalized and announced shortly. Mr. Dabney and his management team are working to make the best deal structure for all shareholders involved, including a CBIS equity stake in CBCA or vice versa. Working together is in the best interests of both CBCA and CBIS as this type of relationship leverages the capabilities, experience, and expertise of both Companies. CBIS seeks to link the capital structure of CBCA with its upcoming asset backed blockchain cryptocurrency ICO, as well as leverage the pharmacies and pharmaceutical drug development programs currently underway as well as in the robust pipeline.

Crown Baus Capital Corp., (www.crownbaus.com) is a global, acquisition-based conglomerate targeting opportunities in drug development, high-tech incubation, entertainment & media, education, and financial services. CBIS is looking to leverage CBCA’s capital structure to access even more additional strength to fast-track the Company’s growth plans for its pharmacy openings and pharmaceutical drug development programs which are consistent with the Company’s aggressive global business development strategy that now will include a proposed asset backed blockchain cryptocurrency ICO offering.

“Alongside our Lawyers and Accountants, we have been working very hard behind the scenes to finish updating the Crown Baus financials and audit to get Crown Baus current and up to date with its SEC/FINRA filings with audited full and transparent disclosures. Now that we have completed the bulk of the work, we are pretty much ready to begin the audit and complete filing of all outstanding financials and exhibits to bring CBCA current on all financials with the SEC/FINRA, This needs to happen regardless and we are in the middle of doing it, so I expect this auditing process to be completed and filed early in 2018,” stated Mr. Raymond C. Dabney, President & CEO, Co-Founder of both Cannabis Science Inc., (CBIS) and Crown Baus Capital Corp., (CBCA).

“These types of agreements closely align with the interests of CBCA and CBIS in drug development and financial security, thus enabling each company to focus on its particular area of expertise. I believe this is a very smart move for a number of reasons, considering the size of the pharmaceutical drug development industry and the newly formed crypto-currency blockchain industry, so we are looking to add two or three engines to this blockchain thing and see what it does. We most certainly believe it will actually put us in a much stronger position to move our projects forward at a much faster growth rate. With California alone having the world’s sixth largest economy with a GDP of 2.5 trillion dollars, this has opened up a very large market for both Companies in our own backyard. I expect the shareholders of CBCA and CBIS to see an increased book value as a direct result of this agreement. Particularly, this relationship will help CBIS to focus on pharmaceutical drug development and will allow CBCA to focus on finance, as well as on future acquisition deals,” stated Mr. Raymond C. Dabney.

CBIS will officially open the first two Cannabis Science Pharmacies in the city of Los Angeles and the greater San Fernando Valley area of Los Angeles. Both pharmacies are scheduled to open January 2018. These pharmacies are looking to meet the expected increased demand in the Los Angeles market from the much-anticipated, new California recreational market influx. These pharmacies will lead to increased access to high quality over the counter pharmaceuticals, nutraceuticals, and cosmeceuticals. Opening these first two pharmacies in Los Angeles is a huge step for Cannabis Science and it will accelerate the Company’s aggressive pharmaceutical expansion plans in the Los Angeles area, throughout California, and eventually nationwide.

Cannabis Science Proposed Asset Backed Blockchain Crypto-Currency ICO

This January 2018 Cannabis Science Inc. plans pre-launch sales of its own proprietary blockchain and will commence ICO trading with a unique three symbol trading symbol on a number of blockchain currency exchange markets after pre-launch sales have completed with similar Bitcoin type ICO trading to follow. The Cannabis Science blockchain white papers are being finalized now for January 2018 release.

From Wikipedia:

Initial coin offering (ICO) is a controversial means of crowdfunding via use of cryptocurrency,[1][2] which can be a source of capital for startup companies.[3] In an ICO, a percentage of the newly issued cryptocurrency is sold to investors in exchange for legal tender or other cryptocurrencies such as Bitcoin or Ethereum.

Early token sales were held by Mastercoin in July 2013 and Ethereum and Karmacoin in 2014, but “mainstream” ICOs began with messaging app developer Kik in September 2017. By November 2017 there were around 50 offerings a month.

ICOs may fall outside existing regulations or may need to be regulated[4][5] depending on the nature of the project, or banned altogether in some jurisdictions, such as China and South Korea. [6][7]

A blockchain,[1][2][3] originally block chain,[4][5] is a continuously growing list of records, called blocks, which are linked and secured using cryptography.[1][6] Each block typically contains a hash pointer as a link to a previous block,[6] a timestamp and transaction data.[7] By design, blockchains are inherently resistant to modification of the data. The Harvard Business Review describes it as “an open, distributed ledger that can record transactions between two parties efficiently and in a verifiable and permanent way.”[8] For use as a distributed ledger, a blockchain is typically managed by a peer-to-peer network collectively adhering to a protocol for validating new blocks. Once recorded, the data in any given block cannot be altered retroactively without the alteration of all subsequent blocks, which requires collusion of the network majority.

Blockchains are secure by design and are an example of a distributed computing system with high Byzantine fault tolerance. Decentralized consensus has therefore been achieved with a blockchain.[9] This makes blockchains potentially suitable for the recording of events, medical records,[10][11] and other records management activities, such as identity management,[12][13][14] transaction processing, documenting provenance, food traceability[15] or voting.[16]

The first blockchain was conceptualized in 2008 by an anonymous person or group known as Satoshi Nakamoto and implemented in 2009 as a core component of bitcoin where it serves as the public ledger for all transactions.[1] The invention of the blockchain for bitcoin made it the first digital currency to solve the double spending problem without the need of a trusted authority or central server. The bitcoin design has been the inspiration for other applications.[1][3]

About Cannabis Science, Inc.

Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

Forward-Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a ‘safe harbor’ for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.

07 Feb

Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada

BEVERLY HILLS, CA–(Marketwired – Feb 7, 2017) –  Crown Baus Capital Corp. (the “Company”) (OTC PINK: CBCA), is a global acquisition-based conglomerate looking to aggressively capitalize on its key industry strengths. Mr. Raymond C. Dabney, Crown Baus President & CEO, is pleased to provide updates in its Drug Development industry; updates in its other key industries will be provided soon. The Company is actively pursuing business opportunities in each of its key industries; High-Tech Incubation, Drug Development, Entertainment & Media, Education, and Financial Services.

To Present your Project: http://www.crownbaus.com/index.php/present-your-project/

Initially, Mr. Dabney and the Team at Crown Baus are structuring an investment management opportunity with Cannabis Science (OTC PINK: CBIS) for participation in its Douglas County, Nevada property and drug development project. Cannabis Science has substantial property development contracts in California and Nevada to build fully licensed, state compliant medicinal and industrial cannabis/hemp production. The Company is splitting the investment opportunities into one-acre parcels for each land development project. Objectives are to build a portfolio of investors, partners, and supply chain production operations throughout the United States that are at various stages of legislative development and leverage our core competencies and strengths. Each project is centered around cultivation and cannabinoid-based drug development programs targeting critical ailments. Each large-scale property and drug development project is designed to generate hundreds of jobs in the construction, farming, medical, retail, and education industries.

Mr. Raymond C. Dabney is the President, CEO & Co-Founder of both Cannabis Science Inc., (OTC PINK: CBIS) and Crown Baus Capital Corp. (OTC PINK: CBCA). Mr. Dabney is looking to include CBCA in the financial management of the Douglas County project. CBIS has announced that it has begun the build-out of its cannabinoid drug development facility in Douglas County, Nevada. Phase 1 of the build-out includes approximately 33,000 sq. ft. of greenhouse space per one-acre plot. The Douglas County land development deal has multiple contracts in place with approximately 15 more acres ready to develop, with more coming shortly thereafter for investor opportunities or CBIS will continue to build them out in- house. Phase 1 for each one acre build-out will cost approximately $300,000 to $500,000 USD with full production capacity maxing out at approximately 33,000 sq. ft., CBCA and the general investing public can benefit from this ground-breaking opportunity by investing directly into the Douglas County property development project, one acre at a time.

Details of the CBIS & CBCA arrangement are pending. Mr. Dabney is working to make the best deal structure for all shareholders involved, including a CBIS shareholder stake in CBCA. Working together is in the best interests of both CBCA and CBIS as this type of relationship makes things much simpler and consequently an exercise of financial strength and growth for both Companies.

California alone has the world’s sixth largest economy with a GDP of 2.5 trillion dollars, thus this opens a very large market for the company to reach. CBIS seeks to link the capital raising abilities of the CBCA Team with the property development projects it has in the works focusing on California, Nevada, and Washington.

About Crown Baus Capital Corp.

Crown Baus Capital Corp. is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment & Media, Education, and Financial Services. We specialize in the vertical integration of industrial, commercial, and retail profit centers, along with partnerships and start-ups, to create synergistic savings and increased value to our shareholders.

Forward-Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition. CrownBaus Capital Corporation does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a ‘safe harbor’ for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.

To Present your Project: http://www.crownbaus.com/index.php/present-your-project/

CONTACT INFORMATION

  • CrownBaus Capital Corp.
    Raymond C. Dabney
    President & CEO, Co-Founder
    T: +1 (888) 263-0948
    info@crownbaus.comCrownBaus Capital Corp.
    Benjamin Tam, CPA
    Chief Financial Officer, (CFO)
    T: +1 (888) 263-0948
    info@crownbaus.com
12 Sep

CrownBaus Capital Corp. Set to Acquire ‘LoudCrush’ Mobile App; “A New Compassionate Kind of Social High”

Crown Baus Capital Corp. (OTC BB: CBCA)  is in the final stage of acquiring niche social and dating app, LoudCrush, which the Company intends to complete with an all equity based transaction by issuing five (5) million dollars worth of its 144 restricted common shares.

LoudCrush will be powered by CrownBaus and will be marketed worldwide by W Agency, a division of WebCongress, Inc., a subsidiary of CrownBaus.

BEVERLY HILLS, Calif., Sept. 12, 2014 /PRNewswire/ — Crown Baus Capital Corp. (OTC BB: CBCAE), a global acquisition-based conglomerate targeting five primary industries: high-tech incubation, drug development, entertainment/media, education, and financial services, is in the final stage of acquiring niche social and dating app, LoudCrush, which the Company intends to complete with an all equity based transaction by issuing five (5) million dollars worth of its 144 restricted common shares.

The initial rollout of LoudCrush will serve the burgeoning community surrounding the U.S. legal cannabis industry with an ArcView Market Research estimated worth of $1.44 billion in 2013 and an expected $2.34 billion in 2014. The features of LoudCrush combine functionality similar to popular apps like Facebook, Tinder and Vine, which allow users to post videos and photos, to search for friends and singles in their areas, and to chat and discreetly socialize. Users can even send gifts.  As development of LoudCrush continues, additional languages will be added to serve larger and larger audiences with a likely first integration of Spanish language functionality.

The beta site is available at www.LoudCrush.com to pre-register for the official launch.

“Most cannabis consumers avoid posting about marijuana on Facebook, Instagram and Twitter because their families and coworkers are on these networks, and cannabis-inclusive profiles are often deleted by mainstream social networks,” said Drue Young, Co-Founder of LoudCrush and Crown Baus Capital Corp. VP of Business Development.

“The LoudCrush mobile app, founded and developed by CrownBaus Vice Presidents Alex Frejrud and Drue Young, provides cannabis-friendly users a place to kick back, relax and socially engage in community discussion, meet, and perhaps find that one true romantic love in an unbiased group community platform,” said Robert Kane, Director and CFO of Crown Baus Capital Corp.  “CrownBaus will add LoudCrush to its value-added Digital Entertainment Division, along with three additional apps, currently in the incubation stage, to be unveiled in the near term.”

As noted above, ArcView estimated in its annual “State of Legal Marijuana Markets” report that the industry is expected to grow to $2.34 billion in 2014. The report projects that in five years, 2018—by which time ArcView expects that 14 states will have legalized retail sales of cannabis—the industry will be worth $10.2 billion. (The illicit market currently is estimated to be between $18 and $30 billion.)  CrownBaus expects growth in the legal cannabis industry to add significantly to the number of LoudCrush users and value of the app.

About Drue Young, CBCA VP of Business Development
Mr. Young’s experience as creative director and designer for high-profile companies and clients in the entertainment and Fortune 500 companies, gives CBCA the additional focused in-house expertise to move much faster in its new product launches. Mr. Young has previously worked with companies such as Wells Fargo Bank, Bank of America, Credit Suisse, H&R Block, Auge Media, The Lourdes Foundation, Hearst Media, Chevrolet, KIA, Scion, AquaHydrate, Chronic Ice Hemp Beverages, FOX, Discovery Communications, SFGate.com, Universal Music Group, and A&E’s hit show Wahlburgers, which received an Emmy nomination.

About Alex Frejrud, CBCA VP of Interactive Strategy
Raised and educated in Sweden, Mr. Frejrud has an extensive background as a telecommunications engineer, film editor, music producer and transmedia pioneer.  Aided by his considerable entrepreneurial skills, Mr. Frejrud has been the driving force behind various successful startups. In 2004, he co-founded the award-winning social network Trig.com. He followed up in 2008 with the establishment of the Glampire Group, consisting of Glampire Labs, Dapptive AB & WebCongress. As director and president of The Glampire Group, he runs and finances various startups and works with a number of renowned record labels, fashion brands, corporations, and movie production companies, enhancing their media strategy, visibility, and connectivity of clients including BMW, MySpace, H&M, Sony, EMI, and Universal Studios.

About WebCongress, Inc.
WebCongress is a leading source for digital marketing strategies, business and new trends in the tech industry. With a database of over 65,000 qualified businesses and the top 200 tech influencers involved, WebCongress events attract 100+ CEOs and over 450 Digital Agencies. The social impact of WebCongress exceeds one million impressions per event, 200 V.I.P bloggers are talking about WebCongress and WebCongress events have been a trending topic on Twitter 9 times.
WebCongress was launched in 2008 by Founder and CEO, Ouali Benmeziane, and it has been growing rapidly ever since. With more than 27 events in 9 different cities attracting powerful speakers from companies like Google, Facebook, Twitter, Youtube, Spotify, Blackberry, Microsoft, Skype, Samsung, Intel and Ericsson, WebCongress is considered to be among the most important Digital marketing events in the world.

About Crown Baus Capital Corp.
Crown Baus Capital Corp. (CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is based in the United States but is already operating globally through its subsidiary, WebCongress, Inc., and Company partners. Crown Baus seeks to add shareholder value through cross-industry synergies and strategic growth.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Crown Baus Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Crown Baus Capital Corp.
Chad S. Johnson, Esq., Director, President & CEO
info@crownbaus.com
www.crownbaus.com
+1 866.784.7239

Investment Inquiries
Robert Kane, Director & CFO
robert.kane@crownbaus.com
+1 561.420.4824

 

21 Aug

UPDATE: Crown Baus Capital Corp (CBCA) Subsidiary WebCongress, Inc. Launches Major Tech Conference in Bogota, Colombia with Speakers from Microsoft, Google, Facebook

CBCA announces the launch of WebCongress’s most recent signature tech and social media conference in Bogota, Colombia today and tomorrow, August 21-22, 2014, one of many editions of WebCongress’s power tech conferences presented in the Americas in 2014-2015.

BEVERLY HILLS, Calif., Aug. 21, 2014 /PRNewswire/ — Crown Baus Capital Corp. (CBCA), a global acquisition-based conglomerate targeting five primary industries: high-tech incubation, drug development, entertainment/media, education, and financial services, announces the launch of WebCongress’s most recent signature tech and social media conference in Bogota, Colombia today and tomorrow, August 21-22, 2014, one of many editions of WebCongress’s power tech conferences presented in the Americas in 2014-2015.

Speakers and discussion leaders from key corporate partners include Microsoft, Google, Facebook, and other powerhouse players in the industry.  They will take the stage with over 1,000 participants today and tomorrow.  The Agenda (and tickets) for this two-day “W Experience” may be seen here, along with speakers, workshops, and discussions.  In addition, the conference includes demonstrations, an educational academy, and the new “W Show”.  The impressive lineup of WebCongress speakers can be found here.

The show will feature a showcase of emerging disruptive technologies featuring devices such as Google Glass, Oculus Rift, Parrot Drones and 3D Printers. The WebCongress team is happy to allow guests a first look at these technologies and demo applications to give attendee’s a first hands on look at the future.

“CBCA’s WebCongress brings incredible expertise and motivation to participants through a multi-platform conference with the best and the brightest of the tech and social media industries sharing their experiences and guidance.  Further, key networking opportunities with professionals from Fortune 100 companies like Microsoft, Google and Facebook add significantly to the value of the ‘W Experience’ in the current edition in Bogota, Colombia and throughout the WebCongress Americas Tour,” said Chad S. Johnson, Esq., Director, President & CEO of Crown Baus Capital Corp.

WebCongress History
WebCongress, founded in 2008 by Ouali Benmeziane, produces digital marketing events across the globe focused on digital strategies. It attracts web professionals, Fortune 500 executives and world-class media outlets from throughout Europe, Latin America and the USA. Since its inception, WebCongress has produced more than 27 events in 9 cities reaching over 100,000 people who have come together to be inspired and educated and to network at WebCongress events. WebCongress also includes the W Agency and The W Academy, offering training and consulting to businesses. It has hosted over 350 hours of training with more than 420 speakers and worked directly with the most prestigious tech and internet companies such as Google, Facebook, Microsoft, Twitter, YouTube, Samsung, Spotify, Skype and Intel, among many others.

About Crown Baus Capital Corp.
Crown Baus Capital Corp., formerly Cannabis Capital Corp. (CBCA), is a United States based global acquisition-based conglomerate targeting five primary industries: high-tech incubation, drug development, entertainment/media, education, and financial services. Crown Baus invests in companies positioned to make a significant impact within their respective industries. These early stage investments provide emerging companies with access to larger capital sums to help elevate their status from start-ups to mature and durable brand leaders, such as with subsidiary WebCongress, Inc.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate” “seek” intend” “believe” “estimate” “expect” “project” “plan” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies the impact of competition and the Company’s reliance on existing regulations. Crown Baus Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Crown Baus Capital Corp.
Chad S. Johnson Esq., Director, President & CEO
www.crownbaus.com
info@crownbaus.com
+1 866.784.7239

Investment Inquiries
Robert Kane, CFO & Director
robert.kane@crownbaus.com
+1 561.420.4824

WebCongress Inc.
Ouali Benmeziane – CEO and Founder – @ouali
www.webcongress.com

WebCongress Inquiries
Monica Gutierrez
monica@webcongress.com

01 Aug

Federal Medical Cannabis Legalization Efforts in Congress Motivates Crown Baus Capital to Initiate its Cannabis Drug Development Program With State-by-State Legal Resources

This federal medical cannabis legalization effort in Congress motivates Crown Baus Capital to complete its negotiations to formally begin its Cannabis Drug Development Program using state-by-state legal resources and distribution.

BEVERLY HILLS, Calif., Aug. 1, 2014 /PRNewswire/ — Crown Baus Capital Corp. (CBCA), a global acquisition-based conglomerate targeting five primary industries: high-tech incubation, drug development, entertainment/media, education, and financial services, sees this week’s Congressional efforts to amend the Controlled Substances Act to permit medical use of cannabis on a nationwide basis as history in the making. This federal medical cannabis legalization effort in Congress motivates Crown Baus Capital to complete its negotiations to formally begin its Cannabis Drug Development Program using state-by-state legal resources and distribution.

The Company has already initiated drug development activity by negotiating to purchase property in several legal medical cannabis states across the country. This, coupled with the expertise of the Company’s drug development partners, Crown Baus Capital expects to be able to fast track cannabis drug development to make these critical cannabis formulations available for those in need on a nationwide basis.

A group of bipartisan U.S. Representatives — Scott Perry (R-Pennsylvania), Dana Rohrabacher (R-California), Steve Cohen (D-Tennessee), and Paul Broun, MD (R-Georgia) — introduced a bill, H.R. 5226, to redefine “marijuana” on a federal legislative level to allow therapeutic, high-CBD cannabis oil to be used to treat seizure disorders. This is a major federal step towards the legalization of medical cannabis, which follows the approval of medical cannabis in nearly half of the states, with many more states actively pursuing legalization for medical and drug development purposes.

In addition, U.S. Senator Rand Paul (R-Kentucky) has announced that he will introduce a bill to reschedule cannabis from its Schedule 1 status under the Controlled Substances Act, so that cannabis can be properly researched, developed, and prescribed for medical purposes. Senator Paul has worked diligently through federal legislation to help states that have legalized medical cannabis.

“Our Drug Development Division’s medical cannabis initiatives are strengthened by this week’s progress in the U.S. House and Senate. These federal developments, in light of the rapid progress on the state level and overwhelming support for medical cannabis among the U.S. voting populace, provide critical forward momentum as the Company positions itself as a leader in the medical cannabis industry,” said Chad S. Johnson, Director, President and CEO of CBCA.

About Crown Baus Capital Corp.
Crown Baus Capital Corp. (CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is based in the United States but is already operating globally through its subsidiary, WebCongress, Inc., and Company partners. Crown Baus seeks to add shareholder value through cross-industry synergies and strategic growth.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Crown Baus Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Crown Baus Capital Corp.
Chad S. Johnson, Esq., Director, President & CEO
info@crownbaus.com
www.crownbaus.com
+1 866.784.7239

Investment Inquiries
Robert Kane, Director & CFO
robert.kane@crownbaus.com
+1 561.420.4824

29 Jul

Cannabis Drug Development Division of Crown Baus Capital Corp. (CBCA) is Motivated by the New York Times Editorial Board Position on ‘Repealing Prohibition, Again’

Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.

BEVERLY HILLS, Calif., July 29, 2014 /PRNewswire/ — Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.

The Editorial Board of the New York Times strongly voiced its opposition to current federal law on cannabis in its Sunday, July 27, 2014 publication writing, “the federal government should repeal the ban on marijuana…. We reached that conclusion after a great deal of discussion among the members of The Times’s Editorial Board, inspired by a rapidly growing movement among the states to reform marijuana laws.”  The newspaper also announces a series of upcoming editorials and articles on the issue called “High Time:  An Editorial Series on Marijuana Legalization”.

“Our Cannabis Drug Development Division sees the New York Times stance on legalizing cannabis as another motivating sign in our efforts to support and invest in the medical cannabis industry, as we are in the process of acquiring or investing in medical cannabis facilities and operations in the U.S. and abroad to help patients in need.  As attitudes and laws change, we want to be at the leading edge of this industry,” said Chad S. Johnson, Director, President and CEO of CBCA.

About Crown Baus Capital Corp.
Crown Baus Capital Corp. (CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is based in the United States but is already operating globally through its subsidiary, WebCongress, Inc., and Company partners. Crown Baus seeks to add shareholder value through cross-industry synergies and strategic growth.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Crown Baus Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Crown Baus Capital Corp.
Chad S. Johnson, Esq., Director, President & CEO
info@crownbaus.com
www.crownbaus.com
+1 866.784.7239

Investment Inquiries
Robert Kane, Director & CFO
robert.kane@crownbaus.com
+1 561.420.4824

25 Jul

Crown Baus Capital Receives FINRA Approval for Name Change, New CUSIP; Crown Baus Continues to Trade Under the Symbol CBCA

The Company is pleased to announce that yesterday, July 24, 2014 Crown Baus Capital Corp. (the “Company”) received approval from FINRA for its previously announced name change from Cannabis Capital Corp.

BEVERLY HILLS, Calif., July 25, 2014 /PRNewswire/ — Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is pleased to announce that yesterday, July 24, 2014 Crown Baus Capital Corp. (the “Company”) received approval from FINRA for its previously announced name change from Cannabis Capital Corp.  (www.crownbaus.com )

As of market open today, July 25, 2014, the Company’s common stock will trade under its new name, Crown Baus Capital, with new CUSIP number of 22821R 101.  The Company’s trading symbol has not changed and will remain as CBCA.

Crown Baus Capital is focused on finalizing the restructuring, internal controls and compliance systems that serve as the proper foundation to take full advantage of the opportunities being considered by management. The Company will continue to expand its team of key executives who will walk these projects through to completion. Recent VP appointments include:

Drue Young – VP of Business Development

Mr. Young’s experience as creative director and a designer for high-profile companies and clients in the entertainment and Fortune 500 companies, gives the Company the additional focused in-house expertise to move much faster in its new product launches. Mr. Young has previously worked with companies such as Wells Fargo Bank, Bank of America, Credit Suisse First Boston, H&R Block, Chevrolet, KIA Motors, Scion, Touchstone Pictures, Discovery Channel, SFGate.com, Universal Music Group, Wahlburgrs, and rappers/actors Ice Cube, Snoop Dogg, and The Game.

Ouali Benmeziane – VP Technology

An expert in SEO, social media and conversion optimization, Mr. Benmeziane (better known as “Ouali”) is the Founder & CEO of WebCongress, Inc., the tech event and consulting company specializing in online marketing and digital trends that has achieved success and recognition in Europe, USA, and LATAM. Trained at the business school IFAG in Paris, Ouali has been offering training and digital marketing consulting for small and large businesses during the past 7 years; teaches at institutes and business schools and speaks at technology events on a global basis. Annually, Ouali brings together thousands of marketers and brand leaders such as Google, Facebook, YouTube, Twitter, BlackBerry and Microsoft in WebCongress events and conferences.

Alex Frejrud – VP of Interactive Strategy

Raised and educated in Sweden, Mr. Frejrud has an extensive background as a telecommunications engineer, film editor, music producer and transmedia pioneer, aided by his considerable entrepreneurial skills. Mr. Frejrud has been the driving force behind various successful startups. In 2004, he co-founded the award-winning social network Trig.com. He followed up in 2008 with the establishment of the Glampire Group, consisting of Glampire Media, Glampire Mobile and Glampire Mobile-Label. As director and president of The Glampire Group, he works with a number of renowned record labels, fashion brands, corporations, websites, and movie production companies, enhancing their media profiles, visibility, viral marketing, and connectivity of clients including BMW, MySpace, H&M, Sony, EMI, and Universal Studios.

“We are very proud of our growing team of experts and we are dedicated to creating the type of innovative environment that embraces novel ideas and transforms them into quality ventures.  Our new name is symbolic of this fundamental concept. We have seen a large number of opportunities and inquiries come into Crown Baus Capital through our relationships, the Internet, the phone lines, and word of mouth. We look forward to advancing our operations very quickly and announcing some of these great projects and opportunities we have committed to put to paper,” said Robert Kane, Director and CFO, Crown Baus Capital Corp.

About Crown Baus Capital Corp.
Crown Baus Capital Corp. (CBCA) is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services. The Company is based in the United States but is already operating globally through its subsidiary, WebCongress, Inc., and Company partners. Crown Baus seeks to add shareholder value through cross-industry synergies and strategic growth.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Crown Baus Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Crown Baus Capital Corp.
Chad S. Johnson, Esq., Director, President & CEO
info@crownbaus.com
www.crownbaus.com
+1 866.784.7239

Investment Inquiries
Robert Kane, Director & CFO
robert.kane@crownbaus.com
+1 561.420.4824

17 Jul

Cannabis Capital Corp. (CBCA) Changes Name to Crown Baus Capital Corp., Better Reflecting Corporate Initiatives and Long-Term Projects

The Company is pleased to announce that its Board of Directors has selected the name Crown Baus Capital Corp. to better reflect the company’s existing and prospective ventures in these five business sectors.

BEVERLY HILLS, Calif., July 17, 2014 /PRNewswire/ — Cannabis Capital Corp. (CBCA) is a global acquisition-based conglomerate targeting five primary industries:  High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.  The Company is pleased to announce that its Board of Directors has selected the name Crown Baus Capital Corp. to better reflect the company’s existing and prospective ventures in these five business sectors.  Simultaneous with this announcement of the corporate name change, the Company’s website www.crownbaus.com has been launched.

The name change began with appropriate regulatory filings with the Office of the Nevada Secretary of State and the name change is currently before the Financial Industry Regulatory Authority (FINRA).  No symbol change is anticipated.  Further, the Crown Baus Capital Corp. name change will have no effect on the Company’s share structure or corporate organization.

The Company recently acquired WebCongress, Inc. as a wholly-owned subsidiary.  WebCongress produces global digital marketing and strategy events, including high-tech educational and consulting programs, attracting technology professionals from start-ups to Fortune 100 corporations, including such companies as Google, Facebook, Twitter, YouTube, Spotify, Blackberry, Microsoft, Skype, Samsung, Intel, and Ericsson.

CBCA has also partnered in the expanding Medical Marijuana Industry seeking to finance FDA-level drug research and development with companies such as Cannabis Science, Inc. (CBIS).  Cannabis Science has already demonstrated success with self-medicating cannabis patients suffering from various cancers, and Crown Baus intends to invest to support groundbreaking clinical trials to further this success.

Crown Baus is also establishing financial and partnership relationships in the media and entertainment sector.  Final negotiations are underway for the Company to purchase an incubator-status television network, a movie studio, and a record label to support its aggressive media exposure department.

President & CEO of Crown Baus Capital Corp., Chad S. Johnson, Esq., stated, “The Company will be persistent in pursuing new opportunities and partnerships within multiple growth industries, identifying synergistic relationships across sectors with a high growth strategy.”

About Crown Baus Capital Corp.
Crown Baus Capital Corp. (CBCA) is a global acquisition-based conglomerate targeting five primary industries:  High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.  The Company is based in the United States but is already operating globally through its subsidiary, WebCongress, Inc., and Company partners.  Crown Baus seeks to add shareholder value through cross-industry synergies and strategic growth.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Crown Baus Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Crown Baus Capital Corp.
Chad S. Johnson, Esq., Director, President & CEO
www.crownbaus.com
info@crownbaus.com
+1 866.784.7239

Investment Inquiries
Robert Kane, Director & CFO
robert.kane@crownbaus.com
+1 561.420.4824

26 Jun

CBCA Subsidiary, WebCongress, Inc. is Proud to be an Official Live Stream Host of the Google I/O Developer Conference Underway June 25-26 in Miami, As Well, Live Stream is Available Globally via http://bit.ly/1lpIVLW

The Company is proud to announce that its subsidiary, WebCongress, Inc., is hosting the official Miami live streaming of the Google I/O Developer Conference.

Concurrently WebCongress Hosts Successful Conference in NYC as Part of its Americas Tour 2014

BEVERLY HILLS, Calif., June 26, 2014 /PRNewswire/ — Cannabis Capital Corp. (CBCA) is an emerging global firm specializing in business development in high tech platforms, media and entertainment, pharmaceutical development, and medical technology. The Company is proud to announce that its subsidiary, WebCongress, Inc., is hosting the official Miami live streaming of the Google I/O Developer Conference. Again, tomorrow, for a second day WebCongress will host the Google I/O Live Stream through Venture Hive from 5-9 pm ET. The event will also be hosting developer sessions that will include Nest for Developers, Hack Your Glass and Predicting the Future with the Google Cloud Platform.

The Google I/O Developer Conference is also being livestreamed internationally and is available for viewing on the following link: http://bit.ly/1lpIVLW. Google I/O first started in 2008 and is one of the premier developer conferences of its kind, attracting thousands of global developers to the conference held at Moscone Center West in San Francisco every year. WebCongress is proud to be a Google Developer Partner, assisting in providing a global audience for Google innovations such as Google Glass and the Google Cloud Platform.

“If you are interested in acquiring a pair of Google Glasses as an Explorer, please visit www.webcongress.com/glass in order to register for the selection process. Google invites its Explorers to provide monthly feedback on battery technology, sound and features for the Google Glasses. One of the many benefits of owning a pair is the title of ‘Explorer’ is extended to you for life,” stated Ouali Benmeziane, Founder & CEO of WebCongress.

WebCongress has concurrently hosted “WebCongress NYC” with an impressive lineup of speakers from around the world speaking about critical topics in the tech arena: http://webcongress.com/newyorkcity/ .  “We at CBCA continue to be impressed by the top-notch reach of WebCongress in all of its professional activities.  WebCongress is quickly becoming the standard in its industry,” said Chad S. Johnson, Esq., Director, President & CEO of CBCA.

WebCongress History
WebCongress, founded in 2008 by Ouali Benmeziane, produces digital marketing events across the globe focused on digital strategies. It attracts web professionals, Fortune 500 executives and world-class media outlets from throughout Europe, Latin America and the USA. Since its inception, WebCongress has produced more than 27 events in 9 cities reaching over 100,000 people who have come together to be inspired and educated and to network at WebCongress events. WebCongress also includes the W Agency and The W Academy, offering training and consulting to businesses. It has hosted over 350 hours of training with more than 420 speakers and worked directly with the most prestigious tech and internet companies such as Google, Facebook, Microsoft, Twitter, YouTube, Samsung, Spotify, Skype and Intel, among many others.

About CBCA
Cannabis Capital Corp. (CBCA) is a United States company actively pursuing investment opportunities in several traditional emerging markets and the rapidly growing global medical cannabis industry. CBCA invests in companies positioned to make a significant impact within their respective industries. These early stage investments provide emerging companies with access to larger capital sums to help elevate their status from start-ups to mature and durable brand leaders, such as WebCongress, Inc. and Cannabis Science Inc., (CBIS).

Recent legislative changes around the world are creating compelling investment opportunities that CBCA is positioned to identify at an early stage.  For example the legal cannabis economy is growing at an aggressive rate as more and more opportunities arise every day as this sector expands from state to state and country to country. Over 20 states and a dozen countries have medical cannabis programs; each creates a unique opportunity for CBCA.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate” “seek” intend” “believe” “estimate” “expect” “project” “plan” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies the impact of competition and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

CBCA
Chad S. Johnson Esq., Director, President & CEO
www.cannabiscapitalcorp.com, info@cannabiscapitalcorp.com
+1 866.784.7239

CBCA Investment Inquiries
Robert Kane, CFO & Director
robert.kane@cannabiscapitalcorp.com
+1 561.420.4824

WebCongress Inc.Ouali Benmeziane – CEO and Founder – @ouali
www.webcongress.com
WebCongress InquiriesMonica Gutierrez
monica@webcongress.com

MEDIA